Florence Wolfender

Florence Wolfender is an accomplished professional in the field of regulatory affairs with extensive experience in biotechnology and pharmaceuticals. Currently serving as Director and Global Regulatory Affairs CMC Team Lead at UCB since November 2018, Florence has a proven track record of securing regulatory approvals across multiple global markets, leading CMC Health Authorities consultations, and defining global regulatory strategies for technology transfers and CMC changes. Prior roles include Associate Director at the Healthcare Business of Merck and Senior Manager at Merck Group, where Florence managed regulatory strategies and approvals for biotech products. Florence has also held key positions at CHUV, B. Braun Group, and Biokema SA, contributing to drug manufacturing, quality control, and regulatory compliance. Educational qualifications include a Diplôme Fédéral de Pharmacien from the University of Lausanne and additional studies at IMD.